Physician Mark Eisenberg discusses the furor over (and the desperate need for) safer injection sites.
As despair deaths reach historic levels in the United States, interventions at health care checkpoints may be the best way to bring them down.
New studies aim to determine what consumers do—or don’t do—after they’ve had a mail-order genome test.
Risk expert David Ropeik argues that despite constant headlines, Americans’ health worries are largely misplaced.
There’s remarkable science behind mail-order gene tests. But should buyers beware?
When a medical mistake is made, full disclosure and a sincere apology could be better for everyone involved.